Catheter Precision's EBIT per Share for the
three
months ended in Mar. 2026 was €-0.69.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-12.87.
During the past 3 years, the average EBIT per Share Growth Rate was 86.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Catheter Precision's EBIT per Share or its related term are showing as below:
FRA:4RM'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 86.5 Med: 86.7 Max: 86.9
Current: 86.5
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Catheter Precision was 86.90% per year. The lowest was 86.50% per year. And the median was 86.70% per year.
FRA:4RM's 3-Year EBIT Growth Rate is ranked better than 97.67% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs FRA:4RM: 86.50
Catheter Precision (FRA:4RM) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Catheter Precision EBIT per Share Related Terms
Catheter Precision EBIT per Share Historical Data
* Premium members only.
The historical data trend for Catheter Precision's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision (FRA:4RM) has a EBIT per Share of €-12.87 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Catheter Precision and its competitors. According to the industry distribution chart, Catheter Precision ranks #16 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 2.3%.
Is Catheter Precision's EBIT per Share too high?
Catheter Precision's current EBIT per Share is €-12.87. Based on the distribution chart, Catheter Precision ranks #16 out of 687 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Catheter Precision has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's EBIT per Share compare to ALURD and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #16 out of 687 companies for EBIT per Share. This places Catheter Precision in the top 2% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Catheter Precision and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current EBIT per Share is €-12.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Catheter Precision (FRA:4RM) has a current EBIT per Share of €-12.87. The stock's GF Value™ is €125.93, compared to a current price of €100.89 — trading 19.9% below its estimated fair value. The current EBIT per Share is €-12.87. Catheter Precision's overall GF Score™ is 32/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Catheter Precision (FRA:4RM), the current EBIT per Share is €-12.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (FRA:4RM) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of €100.89 is trading 19.9% below its estimated GF Value™ of €125.93.
Key valuation signals for FRA:4RM:
EBIT per Share: €-12.87
GF Value™: €125.93 vs. price of €100.89 (19.9% below fair value)
No single metric tells the full story. See the FRA:4RM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
32GF Score
Get the complete analysis for FRA:4RM
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4RM has been successfully added to your 
